T1D Supply Chain and Availability
JDRF has been, and will remain, in close contact with the leading manufacturers of insulin and type one diabetes (T1D) supplies. Each leading manufacturer has shared with us that COVID-19 is not having an impact on their current manufacturing and distribution capabilities. We will continue to monitor the situation and update the T1D community should anything change.
Because of increased orders in recent weeks, some suppliers are telling T1D customers that they may be delayed in immediately refilling orders. We are told that these are delays, not longer-term issues and not due to shortages in the supply chain.
All members of the T1D community should ensure prescriptions are current, and that you have received the maximum number of refills available. Also, consider contacting your pharmacy to see if you are able to refill your prescription even if it is before the typical 30-day time window, as some state and/or health insurance companies are waiving refill restrictions because of COVID-19.
- Can I get insulin without going to a physical pharmacy?
We know some insurers are taking action to make it easier for people to get their insulin through home delivery. We encourage you to reach out to your insurance company or pharmacy to see what options are available to you.
There are a few ways you can lower your prescription and insulin costs: through state and nonprofit programs; diabetes patient assistance programs offered by pharmaceutical companies; medication discount cards and more. Learn more about them at jdrf.org/costs.
On April 7, 2020, Eli Lilly and Company, one of the three major insulin manufacturers, announced that it would provide a co-pay card allowing anyone with or without commercial insurance to buy a month supply of Lilly insulin for $35 or less during the coronavirus pandemic .
- What are the major suppliers saying?
Numerous companies have distributed public statements about their supply chains (listed below). We will provide updates as we receive new information.